Rubedo Life Sciences and SVAX Announce Strategic Partnership During FII Week in Riyadh
SVAX will support Rubedo’s regulatory filings and conduct of Phase 2 clinical trials for lead program, RLS-1496, in the Kingdom of Saudi Arabia and the Emirate of Dubai Partnership builds Rubedo’s footprint as a Hevolution portfolio company and reflects the growing strategic importance of the region in healthy longevity research and the life sciences SAN … [Read more…]
